🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

144,67 USD

Máx. histórico

156,45

70 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-7,53%

Rango 52 semanas

82,01 – 156,92

Variación hoy

-2,49%

Cierre anterior

148,36

Rango de hoy

143,47 – 147,62

Volumen hoy

8.862.415

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,42%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
146,13 (puede no estar actualizado)
Dividend yield
2,29% (puede no estar actualizado)
Precio objetivo analistas
160,29 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 20 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,35%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
19/04/2022 85,97 86,09 85,12 85,79 -0,33% 1,13% 8.494.700
18/04/2022 86,42 87,45 85,68 86,07 -0,97% 2,05% 7.995.100
14/04/2022 86,13 87,51 85,41 86,91 +0,91% 2,44% 22.096.100
13/04/2022 85,80 86,24 84,83 86,13 +0,58% 1,64% 12.743.800
12/04/2022 86,00 86,55 85,22 85,63 -1,15% 1,55% 12.543.000
11/04/2022 88,32 89,48 86,18 86,63 -1,20% 3,74% 14.381.000
08/04/2022 86,64 87,84 86,26 87,68 +1,01% 1,82% 11.409.300
07/04/2022 85,75 87,11 84,96 86,80 +2,15% 2,51% 13.104.300
06/04/2022 84,36 85,56 84,12 84,97 +1,49% 1,71% 13.924.300
05/04/2022 83,66 85,43 83,51 83,72 +0,28% 2,30% 12.040.900
04/04/2022 83,50 83,89 82,73 83,49 -0,04% 1,39% 9.039.600
01/04/2022 82,19 83,58 81,64 83,52 +1,79% 2,36% 10.086.700
31/03/2022 82,90 83,38 81,94 82,05 -0,42% 1,74% 12.466.800
30/03/2022 81,84 82,70 81,67 82,40 +1,02% 1,26% 9.326.600
29/03/2022 81,66 81,76 80,74 81,57 +0,44% 1,25% 7.398.700
28/03/2022 81,37 81,67 80,73 81,21 -0,16% 1,16% 7.071.900
25/03/2022 80,59 81,38 80,45 81,34 +1,16% 1,15% 7.125.600
24/03/2022 80,04 80,67 79,72 80,41 +0,85% 1,19% 7.605.000
23/03/2022 79,30 80,58 79,23 79,73 +0,54% 1,70% 8.470.400
22/03/2022 79,27 79,78 78,77 79,30 +0,30% 1,27% 10.016.600
21/03/2022 79,67 80,45 78,91 79,06 -0,06% 1,93% 10.478.300
18/03/2022 79,18 79,74 78,63 79,11 +0,22% 1,40% 21.064.800
17/03/2022 78,15 79,37 78,06 78,94 +1,05% 1,68% 10.279.400
16/03/2022 78,96 79,11 77,65 78,12 -0,66% 1,85% 10.944.000
15/03/2022 77,68 79,01 77,40 78,64 +1,11% 2,07% 11.403.000
14/03/2022 77,90 78,61 77,31 77,78 -0,61% 1,67% 10.085.400
11/03/2022 78,32 79,63 78,20 78,26 +0,48% 1,83% 9.424.500
10/03/2022 77,63 78,20 77,33 77,89 +0,13% 1,12% 8.972.200
09/03/2022 77,62 78,22 77,05 77,79 +1,09% 1,51% 9.746.000
08/03/2022 77,25 78,09 76,56 76,95 -1,00% 1,98% 10.184.100